Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;37(4):350-355.
doi: 10.1002/pd.5018. Epub 2017 Mar 9.

Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates

Affiliations

Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates

Gabriel A Lazarin et al. Prenat Diagn. 2017 Apr.

Abstract

Objective: To tabulate individual allele frequencies and total carrier frequency for Smith-Lemli-Opitz syndrome (SLOS) and compare expected versus observed birth incidences.

Methods: A total of 262 399 individuals with no known indication or increased probability of SLOS carrier status, primarily US based, were screened for SLOS mutations as part of an expanded carrier screening panel. Results were retrospectively analyzed to estimate carrier frequencies in multiple ethnic groups. SLOS birth incidences obtained from existing literature were then compared with these data to estimate the effect of SLOS on fetal survival.

Results: Smith-Lemli-Opitz syndrome carrier frequency is highest in Ashkenazi Jews (1 in 43) and Northern Europeans (1 in 54). Comparing predicted birth incidence with that observed in published literature suggests that approximately 42% to 88% of affected conceptuses experience prenatal demise.

Conclusion: Smith-Lemli-Opitz syndrome is relatively frequent in certain populations and, because of its impact on prenatal and postnatal morbidity and mortality, merits consideration for routine screening. © 2017 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.

PubMed Disclaimer

References

    1. Kelley RI, Herman GE. Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet 2001;2:299–341. - PubMed
    1. Kelly MN, Tuli SY, Tuli SS, et al. Brothers with Smith–Lemli–Opitz syndrome. J Pediatr Health Care 2014;29:97–103. - PubMed
    1. Kelley RI, Hennekam RCM. The Smith–Lemli–Opitz syndrome. J Med Genet 2000;37:321–35. - PMC - PubMed
    1. Craig WY, Haddow JE, Palomaki GE, et al. Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 2006;26:842–9. - PubMed
    1. Nowaczyk MJM, Waye JS, Douketis JD. DHCR7 mutation carrier rates and prevalence of the RSH/Smith–Lemli–Opitz syndrome: where are the patients? Am J Med Genet Part A 2006;140A:2057–62. - PubMed

LinkOut - more resources